ONCOTELIC THERAPEUTICS
Oncotelic Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology indications. VTTs include vascular disrupting agents (VDAs) such as the investigational drugs that Oncotelic is developing, and anti-angiogenic agents (AAs), a number of which are FDA approved and widely used in cancer treatment. These 2 approaches (VDAs and AAs) have distinct yet complementary mechanisms of action. At Oncotelic, we believe that we can significantly improve cancer therapy by combining these 2 complementary approaches.
ONCOTELIC THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1988-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.oncotelic.com
Total Employee:
11+
Status:
Active
Contact:
(650) 635-7000
Email Addresses:
[email protected]
Total Funding:
7.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps GoDaddy DNS Google Maps API AWS Global Accelerator Akamai Hosted
Similar Organizations
Actimis Pharmaceuticals
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Current Employees Featured
Vuong Trieu
Vuong Trieu Founder, Chairman and CEO @ Oncotelic Therapeutics Founder, Chairman and CEO 2019-04-01
Saran Saund
Saran Saund CBO/ General Manager of AI Division @ Oncotelic Therapeutics CBO/ General Manager of AI Division
Seymour Fein
Seymour Fein CMO @ Oncotelic Therapeutics CMO
Chulho Park
Chulho Park CTO @ Oncotelic Therapeutics CTO
Amit Shah
Amit Shah CFO @ Oncotelic Therapeutics CFO
Anthony E. Maida III
Anthony E. Maida III CHIEF CLINICAL OFFICER-TRANSLATIONAL MEDICIN @ Oncotelic Therapeutics CHIEF CLINICAL OFFICER-TRANSLATIONAL MEDICIN
Larn Hwang
Larn Hwang Chief Scientific Officer @ Oncotelic Therapeutics Chief Scientific Officer 2015-10-01
Founder
Vuong Trieu
Stock Details
Company's stock symbol is OTCQB:OTLC
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-11-04 | PointR Data | PointR Data acquired by Oncotelic Therapeutics | N/A |
2019-04-18 | Oncotelic | Oncotelic acquired by Oncotelic Therapeutics | N/A |
2009-10-01 | VaxGen | VaxGen acquired by Oncotelic Therapeutics | 33 M USD |
2009-07-03 | Symphony Vida | Symphony Vida acquired by Oncotelic Therapeutics | N/A |
Official Site Inspections
http://www.oncotelic.com
- Host name: biz267.inmotionhosting.com
- IP address: 23.235.222.9
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
Loading ...